ENVALITH
ジェイファーマ logo

ジェイファーマ

520AGrowth MarketPharmaceuticals

ジェイファーマ logo
ジェイファーマ520A
Reference Indicators

Market Cap

54¥100M

P/E (Forecast)

P/B

1.3x

Dividend Yield (Forecast)

0.00%

ROE

-60.7%

EV/EBITDA

Financial Summary
Unit: ¥M
Item
2026Mar 2026
SG&A Expenses
695
Operating Income
-3,710
Non-operating Income
1,110
Non-operating Expenses
36
Ordinary Income
-2,636
Extraordinary Income
184
Extraordinary Losses
13
Pre-tax Income
-2,465
Income Taxes
1
Net Income
-2,466
EBITDA
-3,708
ROA
-51.8%
ROE
-60.7%